Pseudochylothorax – Causes, Symptoms and Treatment
Pseudochylothorax is a rare condition in which a milky, turbid fluid accumulates in the pleural space, resembling chyle but characterized by high cholesterol levels.
Things worth knowing about "Pseudochylothorax"
Pseudochylothorax is a rare condition in which a milky, turbid fluid accumulates in the pleural space, resembling chyle but characterized by high cholesterol levels.
What is Pseudochylothorax?
Pseudochylothorax (also known as chyliform pleural effusion) is a rare type of pleural effusion in which a milky, turbid fluid accumulates in the pleural space – the thin cavity between the lungs and the chest wall. Unlike a true chylothorax, which is caused by leaking lymphatic fluid (chyle) and is characterized by elevated triglyceride levels, pseudochylothorax is distinguished by very high concentrations of cholesterol or lecithin-globulin complexes. The condition typically develops slowly over months to years as a consequence of a chronic pleural effusion.
Causes
Pseudochylothorax usually develops from a longstanding, untreated pleural effusion in which cholesterol crystals accumulate in the pleural fluid. Common underlying conditions include:
- Tuberculosis (most common cause worldwide)
- Rheumatoid arthritis with chronic pleural effusion
- Empyema (purulent infection of the pleural space)
- Paragonimiasis (infection by the lung fluke)
- Malignancy (cancers affecting the chest)
- Trauma or previous thoracic surgery
- Rare causes: systemic lupus erythematosus, ankylosing spondylitis
The common underlying mechanism is long-term inflammation of the pleura, leading to a thickened, fibrotic pleural membrane. Impaired drainage of pleural fluid allows cholesterol and lipids to accumulate over time.
Symptoms
The symptoms of pseudochylothorax are often non-specific and depend on the size of the effusion and the underlying disease. Common complaints include:
- Shortness of breath (dyspnea), especially during physical activity
- Chest pain or a feeling of pressure in the chest
- Dry cough
- General fatigue and weakness
- Occasionally fever in cases of concurrent infection
- Unintentional weight loss (when tuberculosis or malignancy is the underlying cause)
Diagnosis
Diagnosing pseudochylothorax requires several diagnostic steps:
Imaging
- Chest X-ray: Detection of pleural effusion
- Computed tomography (CT): Assessment of pleural thickening and exclusion of malignancy
- Ultrasound: Guidance for pleural puncture
Thoracentesis and Laboratory Analysis
Thoracentesis (pleural puncture) is the most important diagnostic step. The retrieved fluid is analyzed for:
- Macroscopic appearance: milky, turbid, whitish fluid
- Cholesterol concentration: elevated (often above 200 mg/dl)
- Triglyceride concentration: normal or low (to exclude true chylothorax)
- Cholesterol-to-triglyceride ratio: greater than 1 (typical of pseudochylothorax)
- Lecithin-globulin complexes may be identified
- Cytology, microbiology, and additional markers to identify the underlying cause
Differentiation from True Chylothorax
The most important differential diagnosis is true chylothorax. In chylothorax, triglyceride levels are elevated (above 110 mg/dl) while cholesterol is normal. In pseudochylothorax, the pattern is reversed, with high cholesterol and normal or low triglycerides.
Treatment
Treatment of pseudochylothorax is primarily directed at the underlying cause and the severity of symptoms.
Treating the Underlying Condition
- For tuberculosis: Anti-tuberculous drug therapy (e.g., isoniazid, rifampicin)
- For rheumatoid arthritis: Anti-rheumatic therapy (DMARDs, corticosteroids)
- For malignancy: Oncological treatment (chemotherapy, radiation therapy)
Drainage Procedures
- Therapeutic thoracentesis: Single or repeated drainage for symptom relief
- Chest tube drainage: For large or symptomatic effusions
- Pleurodesis: Chemical adhesion of the pleural layers to prevent recurrence (e.g., using talc)
Surgical Interventions
- Decortication: Surgical removal of the thickened pleural peel in cases of significantly impaired lung function
- Video-assisted thoracoscopic surgery (VATS): A minimally invasive surgical option
Prognosis
The prognosis of pseudochylothorax depends strongly on the underlying condition. If the root cause is successfully treated, the effusion may resolve. However, complete resolution is rare in cases with long-standing fibrotic pleural disease. Regular follow-up examinations are recommended.
References
- Hillerdal G. - Chylothorax and pseudochylothorax. In: European Respiratory Journal, 1997; 10(5): 1157-1162.
- Staats BA, Ellefson RD, Budahn LL et al. - The lipoprotein profile of chylous and nonchylous pleural effusions. In: Mayo Clinic Proceedings, 1980; 55(11): 700-704.
- Light RW. - Pleural Diseases. 6th edition. Lippincott Williams and Wilkins, 2013.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.